Beam Therapeutics, Inc. (BEAM)
30.50
+0.72
(+2.42%)
USD |
NASDAQ |
Jun 09, 16:00
30.35
-0.15
(-0.49%)
After-Hours: 20:00
Beam Therapeutics SG&A Expense (Quarterly) : 34.43M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 34.84M |
| Twist Bioscience Corp. | 76.08M |
| Caribou Biosciences, Inc. | 8.066M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Oncolytics Biotech, Inc. | 4.729M |